SCHEMBL31092008

SCHEMBL31092008

OC1CCN(c2cc(C(F)(F)F)nc3c(Br)n[nH]c23)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.37
▸ HSP90AB1 P08238 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ IDH2 P48735 5/20 0.35
▸ ADRB2 P07550 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ ADRA2A P08913 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ AXL P30530 1/20 0.33
▸ HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29626809 0.85 HSD17B10 (0.38) ALDH1A1MAPTADRB2KDM4EHPGD
SCHEMBL29626563 0.74 HSP90AA1 (0.40) HSP90AA1HSP90AB1HTR6ATRATRIP
SCHEMBL28741889 0.70 NT5E (0.44) ALDH1A1KDM4E
SCHEMBL31091993 0.69 DHODH (0.34) CNR2
SCHEMBL22944911 0.68 CBLB (0.36) IDH2KDM4EHPGDMAPK1
SCHEMBL1285165 0.64 ADRB2 (0.50) ALDH1A1MEN1MAPTKMT2AADRB2
SCHEMBL31091998 0.63 ADRB2 (0.37) MEN1MAPTKMT2AIDH2ADRB2
SCHEMBL25246123 0.59 HRH4 (0.43) IDH2
SCHEMBL21212248 0.59 CBLB (0.41) HSP90AA1HSP90AB1ALDH1A1MEN1MAPT
SCHEMBL30455420 0.59 HRH4 (0.43) IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450271-B Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition 纽力克斯治疗公司 2024-09-20 — — CN disclosed
Send feedback